Skip to main content
Clinical Trials/IRCT20140804018677N8
IRCT20140804018677N8RecruitingPhase 3

Effects of tumeric (Curcuma longa) and Serrapeptase supplementation on reducing pain and improve range of motion in patients with osteoarthritis of the knee ( a double blind randomized controlled trial)

Shahid Beheshti University of Medical Sciences0 sites80 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
45 years to no limit (—)
Sex
All

Inclusion Criteria

  • age>45y and having knee osteoarthritis according to American College of Rheumatology diagnostic criteria
  • Knee pain with at least three of the followings: age>50, morning stiffness<30 min, crepitation, bone tenderness at knee, knee bone enlargement, warmness or pain in addition to osteophyte according to radiography
  • Grade 2 or 3 of osteoarthritis according to Kellgren and Lawrence system
  • Pain intensity between 5-8 at baseline according to Visual analog scale-VAS
  • Able to walk independently

Exclusion Criteria

  • not having joint arteritis, orthopedic or severe cardiovascular diseases
  • intra-articular injection of corticosteroids in past 3 months, as well as gel, and Platelet-rich plasma (PRP) in past year
  • Severe pain or allergic reaction during intervention that need for Nonsteroidal anti-inflammatory drugs (NSAIDs)
  • unable to complete the study

Investigators

Similar Trials